文献速递临床生化临床免疫

新型液相色谱多反应监测法检测脑脊液神经丝轻链并与超敏免疫分析法比较:迈向标准化

Development of a Novel Liquid Chromatography Coupled to Multiple Reaction Monitoring (LC-MRM) Assay for the Quantification of Neurofilament Light Chain in Cerebrospinal Fluid and Comparison with Ultra-Sensitive Immunoassay: A Step toward Standardization.
PubMed 文献 · Clin Chem · 2026-01-01

研究开发了基于SI溯源校准品的免疫沉淀-液相色谱串联质谱(IP-LC-MS/MS)方法定量脑脊液神经丝轻链(Nf-L),并按ICH指南进行分析验证。对69例脑脊液样本与Lumipulse比较,并在12份脑脊液混合样本中与Simoa和Lumipulse进行头对头比较。三种方法相关性高(r2 > 0.98)但存在系统偏倚,强调Nf-L检测标准化的必要性。

要点

  • IP-LC-MS/MS法采用SI溯源校准品,经ICH指南分析验证。
  • 与Lumipulse结果相关,三种方法r2 > 0.98但存在系统偏倚。
  • 淀粉样蛋白阳性与阴性组间LC-MS/MS结果差异显著(P < 0.05)。

核心结论

  • 新型IP-LC-MS/MS法使用SI溯源校准品,已完成分析和临床验证。
  • 现有免疫分析法之间相关性高但存在偏倚,强化Nf-L测量标准化的需求。

研究设计与样本

  • 开发基于SI溯源校准品的IP-LC-MS/MS方法,按ICH指南进行分析验证。
  • 用MS法和Lumipulse分析69份脑脊液样本,并在12份脑脊液混合样本中头对头比较MS、Simoa和Lumipulse。

主要发现

  • 基于3种肽段的方法通过分析验证。
  • 淀粉样蛋白阳性与阴性组间LC-MS/MS结果差异显著(P < 0.05)。
  • MS与Lumipulse结果相关。
  • 三种方法头对头比较相关性高(r2 > 0.98),但所有技术间均识别出系统偏倚。

临床怎么用

  • 为Nf-L检测提供SI溯源校准的质谱方法,可用于标准化和免疫分析法偏倚评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neurofilament light chain (Nf-L) is a key early biomarker for axonal damage and neurodegeneration, increasingly used in clinical practice for diagnosis, prognosis, and treatment monitoring. To ensure reliable clinical implementation, standardized measurement procedures and calibrators traceable to the International System of Units (SI) are needed. Although a few mass-spectrometry methods for Nf-L quantification in cerebrospinal fluid CSF) and plasma have been described, none currently use properly defined SI-traceable calibrators and existing harmonization efforts rely solely on immunoassays. This study presents a validated immunoprecipitation (IP)-LC-MS/MS assay using an SI-traceable calibrator and compares it with Lumipulse and Simoa platforms to assess agreement and bias. METHODS: A new IP-LC-MS/MS method was developed based on SI-traceable calibrator quantification and analytically validated using International Council for Harmonisation (ICH) guidelines. Analysis of 69 CSF samples by MS assay and Lumipulse (Fujirebio®) was performed as well as head-to-head comparisons between MS, Simoa (Quanterix®) and Lumipulse assays on 12 CSF pools. RESULTS: The method relying on 3 peptides was validated analytically. Significant results (P < 0.05) were obtained between amyloid positive to negative group when using the LC-MS/MS assay. MS and Lumipulse results were correlated. Head-to-head comparison of the 3 methods showed great correlation (r2 > 0.98) but systematic bias was identified between all techniques. CONCLUSION: A new IP-LC-MS/MS method using a SI-traceable calibrator was developed, and analytically and clinically validated. Comparison between available immunoassays resulted in great correlation but biases were identified reinforcing the need of standardization for Nf-L measurement.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Coppens S, Vialaret J, Mondésert E, et al. Development of a Novel Liquid Chromatography Coupled to Multiple Reaction Monitoring (LC-MRM) Assay for the Quantification of Neurofilament Light Chain in Cerebrospinal Fluid and Comparison with Ultra-Sensitive Immunoassay: A Step toward Standardization. Clin Chem. 2026. PMID: 41499262. doi:10.1093/clinchem/hvaf180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。